A Prospective, Multicenter Study on Best Clinical Use of Imatinib in the Advanced Gastrointestinal Stromal Tumors

PHASE2CompletedINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

March 31, 2002

Primary Completion Date

August 31, 2004

Conditions
Advanced Gastrointestinal Stromal Tumors
Interventions
DRUG

Imatinib

Trial Locations (26)

Unknown

Novartis Investigative Site, Ancona

Novartis Investigative Site, Aviano

Novartis Investigative Site, Bari

Novartis Investigative Site, Bergamo

Novartis Investigative Site, Bologna

Novartis Investigative Site, Candiolo

Novartis Investigative Site, Ferrara

Novartis Investigative Site, Florence

Novartis Investigative Site, Genova

Novartis Investigative Site, Livorno

Novartis Investigative Site, Meldola

Novartis Investigative Site, Messina

Novartis Investigative Site, Milan

Novartis Investigative Site, Monserrato

Novartis Investigative Site, Napoli

Novartis Investigative Site, Nola

Novartis Investigative Site, Padua

Novartis Investigative Site, Palermo

Novartis Investigative Site, Perugia

Novartis Investigative Site, Pisa

Novartis Investigative Site, Ravenna

Novartis Investigative Site, Roma

Novartis Investigative Site, Rozzano

Novartis Investigative Site, Sassari

Novartis Investigative Site, Torino

Novartis Investigative Site, Verona

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY